FACULTY


IMMUNOTHERAPY BRIDGE 2016
November 30th 2016



Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Sergio Bracarda
Azienda USL 8, Arezzo

Alfredo Budillon
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Bruno Daniele
Azienda Ospedaliera G. Rummo Benevento

Sabino De Placido
University of Naples "Federico II", Naples, Italy

Cesare Gridelli
A.O.S.G. San Giuseppe Moscati, Avellino, Italy

Hans Hammers
UT Southwestern, Medical Center, Dallas, TX, USA

Vera Hirsh
McGill University Health Centre Cedars Cancer Centre, Montreal, Quebec

Joseph W. Kim
Yale School of Medicine, Yale

Lisa Licitra
Istituto Nazionale dei Tumori "Fondazione IRCCS", Milan, Italy

Rita Nanda
Section of Hematology - Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois

Graham Pawelec
Second Deperment of Internal Medicine, University of Tuebingen, Tuebingen, Germany

David Planchard
Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France

Sandro Pignata
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy




For information please contact info@melanomabridge.org